To investigate the predictive value of pretreatment
18
F-fluorodeoxyglucose (
18
F-FDG) positron emission tomography (PET)/computed tomography (CT) for treatment response and survival outcomes in gastric mucosa-associated lymphoid tissue (MALT) lymphoma patients.
Methods:
F
orty-two patients with newly diagnosed gastric MALT lymphoma were retrospectively analyzed in this study. Each patient underwent
18
F-FDG PET/CT scans before treatment.
18
F-FDG PET/CT results were analyzed using qualitative and semi-quantitative assessment methods: visual assessment and maximal standardized uptake value (SUV
max
). Progression-free survival (PFS) was used as endpoints to evaluate prognosis.
Results:
Patients were followed for 13 to 80 months with a mean of (38.916.5) months. PET positivity and high SUV
max
were significantly associated with inferior PFS. Multivariate analysis showed that SUV
max
was the only independent predictor of PFS (HR=11.283
P
=0.022). SUV
max
could also independently predict the treatment response (OR=8.750
P
=0.005).
Conclusion:
Pretreatment
18
F-FDG PET/CT can predict treatment response and survival outcomes in gastric MALT lymphoma patients.
Evaluation of prostate cancer across different treatment stages using 18F-FDG PET imaging
Advances in the development of TROP2-targeted nuclear medicine molecular imaging probes
A case of invasive lobular carcinoma of the breast with multiple metastases underwent 68Ga-FAPI and 18F-FDG PET/CT imaging
Comparison of 18F-FDG PET/CT and 68Ga-FAPI PET/CT in diagnosis of different types of lymphoma
The value of 68 Ga-FAP-2286 PET/CT in predicting the survival of patients with advanced digestive system malignant tumors after treatment
Related Author
Chu WANG
Jiangyu MA
Tuo LI
Chao FU
Linfeng LI
Hongli JING
Li HUO
Xingfang HONG
Related Institution
Clinical Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences
Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Comprehensive Laboratory of Pathogenic Biology, School of Basic Medical Sciences, Medical Department of Dali University, Dali
Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Center for Biomedical Imaging, Fudan University, Shanghai Engineering Research Center of Molecular Imaging Probes